Measuring expression levels of small regulatory RNA molecules from body fluids and formalin-fixed, paraffin-embedded samples

Methods in Molecular Biology

Volumn 1182, Issue , 2014, Pages 105-119

  Gyongyosi, Adrienn ^a   Docs, Otto ^a   Czimmerer, Zsolt ^a   Orosz, Laszlo ^a   Horvath, Attila ^a   Török, Olga ^a   Mehes, Gabor ^a   Nagy, Laszlo ^a   Balint, Balint L ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Cancer; FFPE; miRNA; RT qPCR; Stem loop; Urine

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FORMALDEHYDE; HSA MIR 325; HSA MIR 515 3P; MICRORNA; MICRORNA 155; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE; PARAFFIN; SMALL NUCLEOLAR RNA; UNCLASSIFIED DRUG; MIRN325 MICRORNA, HUMAN; MIRN515 MICRORNA, HUMAN;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EMBEDDING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MONOTHERAPY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINALYSIS; URINE; ANIMAL; BODY FLUID; CHEMISTRY; GENE EXPRESSION PROFILING; HIGH THROUGHPUT SEQUENCING; PROCEDURES;

ANIMALS; BODY FLUIDS; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICRORNAS; PARAFFIN; PARAFFIN EMBEDDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84925884451     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1062-5_10     Document Type: Article

References (25)

1. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297
2. Huntzinger E, Izaurralde E (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12: 99-110
3. Ivey KN, Srivastava D (2010) MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell 7: 36-41
4. Baltimore D, Boldin MP, O'Connell RM et al (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9: 839-845
5. Tili E, Michaille JJ, Costinean S et al (2008) MicroRNAs, the immune system and rheumatic disease. Nat Clin Pract Rheumatol 4: 534-541
6. Du L, Pertsemlidis A (2011) Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation. J Mol Cell Biol 3: 176-180
7. Weber JA, Baxter DH, Zhang S et al (2010) The microRNA spectrum in 12 body fl uids. Clin Chem 56: 1733-1741
8. Xi Y, Nakajima G, Gavin E et al (2007) Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fi xed paraffi n-embedded samples. RNA 13: 1668-1674
9. Jung M, Schaefer A, Steiner I et al (2010) Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin Chem 56: 998-1006
10. Hui A, How C, Ito E et al (2011) Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer 11: 500
11. Mengual L, Lozano JJ, Ingelmo-Torres M et al (2013) Using microRNA profi ling in urine samples to develop a non-invasive test for bladder cancer. Int J Cancer 133: 2631-2641
12. Shen N, Liang D, Tang Y et al (2012) MicroRNAs-novel regulators of systemic lupus erythematosus pathogenesis. Nat Rev Rheumatol 8: 701-709
13. Alevizos I, Illei GG (2010) MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 6: 391-398
14. Mattie MD, Benz CC, Bowers J et al (2006) Optimized high-Throughput microRNA expression profi ling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5: 24
15. Rosenfeld N, Aharonov R, Meiri E et al (2008) MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26: 462-469
16. Lu J, Getz G, Miska EA et al (2005) MicroRNA expression profi les classify human cancers. Nature 435: 834-838
17. Takamizawa J, Konishi H, Yanagisawa K et al (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756
18. Hayashita Y, Osada H, Tatematsu Y et al (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632
19. Chen JQ, Russo J (2009) ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches. Biochim Biophys Acta 1796: 162-175
20. Chen C, Ridzon DA, Broomer AJ et al (2005) Real-Time quantifi cation of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179
21. Varkonyi-Gasic E, Wu R, Wood M et al (2007) Protocol: a highly sensitive RT-PCR method for detection and quantifi cation of microRNAs. Plant Methods 3: 12
22. Czimmerer Z, Hulvely J, Simandi Z et al (2013) A versatile method to design stem-loop primer-based quantitative PCR assays for detecting small regulatory RNA molecules. PLoS One 8: e55168
23. Shibuya H, Iinuma H, Shimada R et al (2010) Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 79: 313-320
24. Becker C, Hammerle-Fickinger A, Riedmaier I et al (2010) mRNA and microRNA quality control for RT-qPCR analysis. Methods 50: 237-243
25. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408